Global Information
회사소개 | 문의 | 비교리스트

방사성 의약품 시장 : 세계 산업 인사이트, 동향, 전망, 기회 분석(2016-2024년)

Radiopharmaceuticals Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

리서치사 Coherent Market Insights
발행일 2019년 05월 상품 코드 865082
페이지 정보 영문
가격
US $ 4,500 ₩ 5,347,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,318,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,884,000 PPT Turned PDF (Enterprise User License)


방사성 의약품 시장 : 세계 산업 인사이트, 동향, 전망, 기회 분석(2016-2024년) Radiopharmaceuticals Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 방사성 의약품 시장은 루타테라(Lutathera)를 비롯한 방사성 핵종의 신규 승인, 방사성 의약품의 용도 확대, 단클론항체의 방사성 표지, 암과 알츠하이머병 등의 조기진단 필요성 증대 등에 의해 성장이 가속화할 전망입니다.

세계의 방사성 의약품(Radiopharmaceuticals) 시장을 조사했으며, 시장 개요, 제품 종류·용도·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 범위

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 제품 종류별
    • 시장 개요 : 용도별
    • 시장 개요 : 최종사용자별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 규제 시나리오
  • 상환 시나리오
  • PEST 분석
  • Five Forces 분석
  • 협업 및 제휴
  • 인수합병
  • 주요 발전
  • 역학

제4장 세계의 방사성 의약품 시장 : 제품 종류별

  • 서론
  • 진단용 핵의학
  • 치료용 핵의학

제5장 세계의 방사성 의약품 시장 : 용도별

  • 서론
  • 종양
  • 순환기
  • 신경
  • 내분비
  • 기타

제6장 세계의 방사성 의약품 시장 : 최종사용자별

  • 서론
  • 병원
  • 전문클리닉
  • 진단센터

제7장 세계의 방사성 의약품 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 아프리카
  • 중동

제8장 경쟁 환경

  • 히트 맵 분석
  • 기업 개요
    • Progenics Pharmaceuticals, Inc.
    • NorthStar Medical Radioisotopes LLC
    • Curium Pharma
    • Life Molecular Imaging
    • Lantheus Holdings, Inc.
    • Cardinal Health, Inc.
    • General Electric Company
    • Bracco S.p.A.
    • Bayer AG
    • Advanced Accelerator Applications, S.A.
    • Eli Lilly and Company

제9장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.06.25

Licensing, regulations, and use of radioisotopes in the U.S. is under agencies such as the U.S. Nuclear Regulatory Commission (NRC), the U.S. Environmental Protection Agency (EPA), the U.S. Food & Drug Administration (FDA), and respective state governments. The state governments are responsible for regulating radioactive substances that occur naturally or are produced by linear accelerators and/or cyclotrons, and EPA is responsible for among other things, setting air emission and drinking water standards for radionuclides. The U.S. Food and Drug Administration (FDA) regulates manufacturing and use of linear accelerators; granting marketing authorizations to radiopharmaceutical products for diagnostic as well as therapeutic use and other activities associated with radiopharmaceutical products.

Market Dynamics

Factors such as approval of products such as Lutathera, a potential blockbuster drug (Advanced Accelerator Applications, 2018) and Axumin (2016, Blue Earth Diagnostics) has propelled global radiopharmaceuticals in nuclear medicine market growth. Newer trends such as increasing therapeutic applications of radiopharmaceuticals and radiolabeling of monoclonal antibodies are expected to support growth of the market. Subsequently, as the need for early diagnosis of diseases such as cancer and accurate diagnosis of diseases such as Alzheimer's has become more necessary (certain products have come close to this such as Amyvid and Vizamyl) radiopharmaceuticals are expected to find an even strong foothold in medical care.

Key features of the study:

  • This report provides in-depth analysis of global radiopharmaceuticals in nuclear medicine market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global radiopharmaceuticals in nuclear medicine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global radiopharmaceuticals in nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global radiopharmaceuticals in nuclear medicine market

Detailed Segmentation:

  • Global Radiopharmaceuticals in Nuclear Medicine Market, By Product Type:
  • Diagnostic Nuclear Medicine
    • SPECT Radiopharmaceuticals
    • Tc-99m
    • In-111
    • Tl-201
    • Ga-67
    • I-123/I-125/I-131
    • Other SPECT Isotopes
    • PET Radiopharmaceuticals
    • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
    • Ru-82
    • Other PET Isotopes
  • Therapeutic Nuclear Medicine
    • Ra-223
    • I-131
    • Re-186/Sm-153/Sr-90
    • Lu-177
    • Ir-192
    • Pd-103
    • Cs-131
    • Others
  • Global Radiopharmaceuticals in Nuclear Medicine Market, By Application:
  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Others
  • Global Radiopharmaceuticals in Nuclear Medicine Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Global Radiopharmaceuticals in Nuclear Medicine Market, By Region:
  • North America
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country:
    • U.S.
    • Canada
  • Europe
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country:
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • In-111
  • Tl-201
  • Ga-67
  • I-123/I-125/I-131
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • F-18 Florbetapir/Flutemetamol/ Florbetaben
  • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
  • Fluorine-18 Fluciclovine
  • Other F-18 Isotopes
  • Ru-82
  • Other PET Isotopes
    • Therapeutic Nuclear Medicine
  • Ra-223
  • I-131
  • Re-186/Sm-153/Sr-90
  • Lu-177
  • Ir-192
  • Pd-103
  • Cs-131
  • Others
    • By Application:
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Others
    • By End User:
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
  • Progenics Pharmaceuticals, Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • NorthStar Medical Radioisotopes LLC
  • Curium Pharma
  • Life Molecular Imaging
  • Lantheus Holdings, Inc.
  • Cardinal Health, Inc.
  • General Electric Company
  • Bracco S.p.A.
  • Bayer AG
  • Advanced Accelerator Applications, S.A.
  • Eli Lilly and Company

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • PEST Analysis
  • Porter's Analysis
  • Collaborations & Partnerships
  • Mergers & Acquisitions
  • Key Developments
  • Epidemiology

4. Global Radiopharmaceuticals in Nuclear Medicine Market, By Product Type, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Diagnostic Nuclear Medicine
    • SPECT Radiopharmaceuticals
    • Tc-99m
    • In-111
    • Tl-201
    • Ga-67
    • I-123/I-125/I-131
    • Other SPECT Isotopes
    • PET Radiopharmaceuticals
    • F-18
    • F-18 Florbetapir/Flutemetamol/ Florbetaben
    • F-18-Fluoro-Deoxy-Glucose (18F-FDG)
    • Fluorine-18 Fluciclovine
    • Other F-18 Isotopes
    • Ru-82
    • Other PET Isotopes
  • Therapeutic Nuclear Medicine
    • Ra-223
    • I-131
    • Re-186/Sm-153/Sr-90
    • Lu-177
    • Ir-192
    • Pd-103
    • Cs-131
    • Others

5. Global Radiopharmaceuticals in Nuclear Medicine Market, By Application, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

6. Global Radiopharmaceuticals in Nuclear Medicine Market, By End User, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, 2018-2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)

7. Global Radiopharmaceuticals in Nuclear Medicine Market, By Regions, 2016-2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016-2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016-2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Progenics Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • NorthStar Medical Radioisotopes LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Curium Pharma
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Life Molecular Imaging
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Lantheus Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • General Electric Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bracco S.p.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Advanced Accelerator Applications, S.A.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q